NCT05571813

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

An Open-label, Randomized, Fasted, Single-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Between Administration of CKD-341 and Administration of D958 in Healthy Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

Detailed description

An open-label, randomized, fasted, single-dose, three-way crossover study to compare the pharmacokinetic characteristics and safety between administration of CKD-341 and administration of D958 in healthy adults

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-341	A single dose of 1tablets under fasting condition

Timeline

• Start date: 2022-11-02
• Primary completion: 2022-12-04
• Completion: 2022-12-23
• First posted: 2022-10-07
• Last updated: 2023-03-22

Locations

1 site across 1 country: South Korea